Nevertheless, with 10-year FU, AIB1 was found to be an independent prognostic factor for BCM after adjustment for age, tumor size, nodal status, NHG, Ki67, luminal-like classification, and adjuvant systemic therapy. This evidence concerns the gene NCOA3 and blue cone monochromacy.